StockData
OKYONasdaqBiological Products, (No Diagnostic Substances)

OKYO Pharma Ltd

Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Jul 20, 2026
$1.40−0.01 (-0.71%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
–
Dividend yield
–

Earnings

Quarterly results announced on Form 8-K, Item 2.02

No earnings releases found

OKYO Pharma has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.

Press releases

Announcements OKYO Pharma filed with the SEC